BOXABAN Trademark

Trademark Overview

On Monday, May 14, 2012, a trademark application was filed for BOXABAN with the United States Patent and Trademark Office. The USPTO has given the BOXABAN trademark a serial number of 85624288. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 19, 2025. This trademark is owned by Cumberland Pharmaceuticals Inc.. The BOXABAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease
boxaban

General Information

Serial Number85624288
Word MarkBOXABAN
Filing DateMonday, May 14, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 19, 2025
Registration Number4752220
Registration DateTuesday, June 9, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 19, 2025
Primary Code005
First Use Anywhere DateWednesday, April 15, 2015
First Use In Commerce DateWednesday, April 15, 2015

Trademark Owner History

Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Thursday, May 17, 2012NEW APPLICATION ENTERED
Friday, May 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 5, 2012ASSIGNED TO EXAMINER
Wednesday, September 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 9, 2012PUBLISHED FOR OPPOSITION
Tuesday, October 9, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 20, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 20, 2013SOU EXTENSION 1 FILED
Wednesday, June 19, 2013SOU EXTENSION 1 GRANTED
Thursday, June 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2013SOU EXTENSION 2 FILED
Monday, November 4, 2013SOU EXTENSION 2 GRANTED
Tuesday, November 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 2, 2014SOU TEAS EXTENSION RECEIVED
Monday, June 2, 2014SOU EXTENSION 3 FILED
Wednesday, June 4, 2014SOU EXTENSION 3 GRANTED
Thursday, June 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 4, 2014SOU TEAS EXTENSION RECEIVED
Thursday, December 4, 2014SOU EXTENSION 4 FILED
Wednesday, December 10, 2014SOU EXTENSION 4 GRANTED
Thursday, December 11, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 28, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, April 28, 2015USE AMENDMENT FILED
Saturday, May 2, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, May 4, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 5, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 9, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 8, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 21, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 21, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 10, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 19, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

boxaban patients artery disease peripheral pulmonary preparations pharmaceutical hypertension